The efficacy of resistance exercise training and nutritional supplementation of calcium, vitamin D and protein on musculoskeletal health, cardiometabolic risk factors and health-related quality of life in prostate cancer survivors treated with androgen deprivation therapy when compared to usual care

Deakin University0 sites70 target enrollmentMarch 25, 2014

Overview

Phase: N/A
Intervention: Not specified
Conditions: Prostate cancer survivors treated with androgen deprivation therapy
Sponsor: Deakin University
Enrollment: 70
Status: Completed
Last Updated: 6 years ago

No summary available.

Registry

who.int

Start Date

March 25, 2014

End Date

August 1, 2019

Last Updated

6 years ago

Study Type

Interventional

Sex

Male

Sponsor

•Men aged 50\-85 years currently undergoing treatment for prostate cancer with androgen deprivation therapy. Treatment with androgen deprivation therapy must be planned to be continuous, pharmacological, administered for greater than three months at enrollment and expected to be administered for the duration of the intervention (52 weeks). All participants in the study must also have received approval from their local physician to participate in the study.

•do not have the ability to complete surveys in the English language; any disorder known to affect bone, calcium or vitamin D metabolism (other than hypogonadism); currently receiving pharmacological intervention known to affect bone metabolism (other than androgen deprivation therapy); supplementation with protein, calcium (\>600 mg/d) or vitamin D (\>1000 IU/d) in the past three months; have undertaken progressive resistance training (\>1 session/wk) or high impact weight bearing exercise (\>150 min/wk) in the past three months; current smokers; weight greater than 159kg; have plans to travel for greater than six weeks continuously within the following 52 weeks; any absolute contraindications to exercise training according to the American College of Sports Medicine guidelines.